Literature DB >> 15204926

Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development.

Sonia R Navas-Martín1, Susan Weiss.   

Abstract

A novel coronavirus has been recently identified as the causative agent of the severe acute respiratory syndrome (SARS) outbreak that has accounted for more than 8000 infected people worldwide. This review will discuss current knowledge on coronavirus replication, pathogenesis, evolution, and vaccine strategies, as well as the most recent findings on SARS coronavirus.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15204926      PMCID： PMC7095027          DOI： 10.1080/13550280490280292

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


  130 in total

Review 1.  CD8 T cell mediated immunity to neurotropic MHV infection.

Authors:  C C Bergmann; N W Marten; D R Hinton; B Parra; S A Stohlman
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

2.  Coronavirus mRNA synthesis: identification of novel transcription initiation signals which are differentially regulated by different leader sequences.

Authors:  N La Monica; K Yokomori; M M Lai
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

3.  Immunogenicity of JHM virus proteins: characterization of a CD4+ T cell epitope on nucleocapsid protein which induces different T-helper cell subsets.

Authors:  R C van der Veen
Journal:  Virology       Date:  1996-11-15       Impact factor: 3.616

4.  Persistence of viral RNA in the central nervous system of mice inoculated with MHV-4.

Authors:  J O Fleming; J J Houtman; H Alaca; H C Hinze; D McKenzie; J Aiken; T Bleasdale; S Baker
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

5.  RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2.

Authors:  J G Keck; L H Soe; S Makino; S A Stohlman; M M Lai
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  WHO declares Beijing to be free of SARS.

Authors:  Haroon Ashraf
Journal:  Lancet       Date:  2003-06-28       Impact factor: 79.321

7.  Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome.

Authors:  Emily C W Hung; Stephen S C Chim; Paul K S Chan; Yu K Tong; Enders K O Ng; Rossa W K Chiu; Chi-Bon Leung; Joseph J Y Sung; John S Tam; Y M Dennis Lo
Journal:  Clin Chem       Date:  2003-12       Impact factor: 8.327

8.  A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae.

Authors:  J M González; P Gomez-Puertas; D Cavanagh; A E Gorbalenya; Luis Enjuanes
Journal:  Arch Virol       Date:  2003-11       Impact factor: 2.574

9.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.

Authors:  Christl A Donnelly; Azra C Ghani; Gabriel M Leung; Anthony J Hedley; Christophe Fraser; Steven Riley; Laith J Abu-Raddad; Lai-Ming Ho; Thuan-Quoc Thach; Patsy Chau; King-Pan Chan; Tai-Hing Lam; Lai-Yin Tse; Thomas Tsang; Shao-Haei Liu; James H B Kong; Edith M C Lau; Neil M Ferguson; Roy M Anderson
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

10.  Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever.

Authors:  R C Weiss; F W Scott
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1981       Impact factor: 2.268
View more
  29 in total

1.  Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus.

Authors:  Pedro Serrano; Margaret A Johnson; Marcius S Almeida; Reto Horst; Torsten Herrmann; Jeremiah S Joseph; Benjamin W Neuman; Vanitha Subramanian; Kumar S Saikatendu; Michael J Buchmeier; Raymond C Stevens; Peter Kuhn; Kurt Wüthrich
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

2.  Lineage A Betacoronavirus NS2 Proteins and the Homologous Torovirus Berne pp1a Carboxy-Terminal Domain Are Phosphodiesterases That Antagonize Activation of RNase L.

Authors:  Stephen A Goldstein; Joshua M Thornbrough; Rong Zhang; Babal K Jha; Yize Li; Ruth Elliott; Katherine Quiroz-Figueroa; Annie I Chen; Robert H Silverman; Susan R Weiss
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

Review 3.  Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.

Authors:  Susan R Weiss; Sonia Navas-Martin
Journal:  Microbiol Mol Biol Rev       Date:  2005-12       Impact factor: 11.056

4.  Infectious bronchitis virus 3a protein localizes to a novel domain of the smooth endoplasmic reticulum.

Authors:  Amanda R Pendleton; Carolyn E Machamer
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein.

Authors:  Sonia Navas-Martin; Susan T Hingley; Susan R Weiss
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 6.  Emergence of SARS-CoV-2 New Variants and Their Clinical Significance.

Authors:  Hitesh Singh; Nisha Dahiya; Mahima Yadav; Neelam Sehrawat
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-05-28       Impact factor: 2.585

7.  Nuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold.

Authors:  Amarnath Chatterjee; Margaret A Johnson; Pedro Serrano; Bill Pedrini; Jeremiah S Joseph; Benjamin W Neuman; Kumar Saikatendu; Michael J Buchmeier; Peter Kuhn; Kurt Wüthrich
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

8.  Crystallization and preliminary X-ray diffraction analysis of the N-terminal domain of human coronavirus OC43 nucleocapsid protein.

Authors:  I Jung Chen; Chia Cheng Chou; Chia Ling Liu; Cheng Chung Lee; Lou Sing Kan; Ming Hon Hou
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-06-24

Review 9.  The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2).

Authors:  Narasimha M Beeraka; SubbaRao V Tulimilli; Medha Karnik; Surya P Sadhu; Rajeswara Rao Pragada; Gjumrakch Aliev; SubbaRao V Madhunapantula
Journal:  Biomed Res Int       Date:  2021-06-01       Impact factor: 3.411

10.  A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.

Authors:  Julie E Martin; Mark K Louder; LaSonji A Holman; Ingelise J Gordon; Mary E Enama; Brenda D Larkin; Charla A Andrews; Leatrice Vogel; Richard A Koup; Mario Roederer; Robert T Bailer; Phillip L Gomez; Martha Nason; John R Mascola; Gary J Nabel; Barney S Graham
Journal:  Vaccine       Date:  2008-09-26       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.